These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31227475)

  • 1. Sickle cell disease: a new era.
    Simpson S
    Lancet Haematol; 2019 Aug; 6(8):e393-e394. PubMed ID: 31227475
    [No Abstract]   [Full Text] [Related]  

  • 2. Time to Invest in Sickle Cell Anemia as a Global Health Priority.
    McGann PT
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244863
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing Costs, Benefits, and Risks in Chronic Disease: Taking the Long View.
    Saenz C; Tisdale JF
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1149-50. PubMed ID: 25783634
    [No Abstract]   [Full Text] [Related]  

  • 4. Food and Drug Administration Approval of Glutamine for Sickle Cell Disease: Success and Precautions in Glutamine Research.
    Wilmore DW
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):912-917. PubMed ID: 28858569
    [No Abstract]   [Full Text] [Related]  

  • 5. New and experimental agents for sickle cell disease.
    Ataga KI
    Clin Adv Hematol Oncol; 2018 Jul; 16(7):476-479. PubMed ID: 30067617
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost of health care for patients with sickle cell disease.
    Ballas SK
    Am J Hematol; 2009 Jun; 84(6):320-2. PubMed ID: 19415728
    [No Abstract]   [Full Text] [Related]  

  • 7. Addressing the global health burden of sickle cell disease.
    Carey PJ
    Int Health; 2014 Dec; 6(4):269-70. PubMed ID: 25002691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and new horizons for sickle cell disease.
    The Lancet Haematology
    Lancet Haematol; 2018 Feb; 5(2):e53. PubMed ID: 29406146
    [No Abstract]   [Full Text] [Related]  

  • 9. L-glutamine for sickle cell disease: Knight or pawn?
    Sadaf A; Quinn CT
    Exp Biol Med (Maywood); 2020 Jan; 245(2):146-154. PubMed ID: 31985279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell anaemia: epidemiology and cost of illness.
    Nietert PJ; Silverstein MD; Abboud MR
    Pharmacoeconomics; 2002; 20(6):357-66. PubMed ID: 12052095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease expenditures and outcomes.
    Schechter AN
    Public Health Rep; 1997; 112(1):38-9. PubMed ID: 9018286
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sickle cell anemia and social vulnerability, an accumulation of handicaps].
    Agenet J
    Soins Pediatr Pueric; 2007 Feb; (234):34-6. PubMed ID: 17338416
    [No Abstract]   [Full Text] [Related]  

  • 13. Hospital resource utilization among patients with sickle cell disease.
    Mayer ML; Konrad TR; Dvorak CC
    J Health Care Poor Underserved; 2003 Feb; 14(1):122-35. PubMed ID: 12613072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sickle cell disease: taking care of more and older patients].
    Galactéros F
    Rev Prat; 2004 Sep; 54(14):1529-30. PubMed ID: 15558960
    [No Abstract]   [Full Text] [Related]  

  • 15. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    Niihara Y; Miller ST; Kanter J; Lanzkron S; Smith WR; Hsu LL; Gordeuk VR; Viswanathan K; Sarnaik S; Osunkwo I; Guillaume E; Sadanandan S; Sieger L; Lasky JL; Panosyan EH; Blake OA; New TN; Bellevue R; Tran LT; Razon RL; Stark CW; Neumayr LD; Vichinsky EP;
    N Engl J Med; 2018 Jul; 379(3):226-235. PubMed ID: 30021096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone-marrow transplantation in sickle-cell anaemia: why so few so late?
    Ballas SK
    Lancet; 1992 Nov; 340(8829):1226. PubMed ID: 1359294
    [No Abstract]   [Full Text] [Related]  

  • 17. Invasive infections and sickle-cell disease.
    Adamkiewicz T
    Lancet Infect Dis; 2010 Sep; 10(9):593; author reply 593-4. PubMed ID: 20797638
    [No Abstract]   [Full Text] [Related]  

  • 18. Affordable HIV and sickle cell disease gene therapies.
    Mullard A
    Nat Rev Drug Discov; 2019 Nov; 18(12):895. PubMed ID: 31780850
    [No Abstract]   [Full Text] [Related]  

  • 19. The painful face of poverty.
    Hankins J; Wang W
    Pediatr Blood Cancer; 2009 Feb; 52(2):157-8. PubMed ID: 19021225
    [No Abstract]   [Full Text] [Related]  

  • 20. Sickle cell disease: Status with particular reference to India.
    Rees DC; Brousse VA
    Indian J Med Res; 2016 Jun; 143(6):675-677. PubMed ID: 27748289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.